Page last updated: 2024-09-04

tipifarnib and Colonic Neoplasms

tipifarnib has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerman, O; Burvenich, I; Cornelissen, B; Kersemans, V; Oltenfreiter, R; Slegers, G; Vanderheyden, JL; Vandewiele, C	1
Borner, MM	1

Reviews

1 review(s) available for tipifarnib and Colonic Neoplasms

Article	Year
[Molecular targets in colon cancer]. Therapeutische Umschau. Revue therapeutique, 2006, Volume: 63, Issue:4 Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Cetuximab; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Drug Delivery Systems; ErbB Receptors; Gefitinib; Humans; Imatinib Mesylate; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolones; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin; Signal Transduction; Sirolimus; Sunitinib	2006

Article

Year

[Molecular targets in colon cancer].

Therapeutische Umschau. Revue therapeutique, 2006, Volume: 63, Issue:4

Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Cetuximab; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Drug Delivery Systems; ErbB Receptors; Gefitinib; Humans; Imatinib Mesylate; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolones; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin; Signal Transduction; Sirolimus; Sunitinib

2006

Other Studies

1 other study(ies) available for tipifarnib and Colonic Neoplasms

Article	Year
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor. Nuclear medicine communications, 2005, Volume: 26, Issue:2 Topics: Alkyl and Aryl Transferases; Animals; Biomarkers, Tumor; Cell Line, Tumor; Colonic Neoplasms; Epidermal Growth Factor; ErbB Receptors; Farnesyltranstransferase; Humans; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organotechnetium Compounds; Quinolones; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome	2005

Article

Year

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.

Nuclear medicine communications, 2005, Volume: 26, Issue:2

Topics: Alkyl and Aryl Transferases; Animals; Biomarkers, Tumor; Cell Line, Tumor; Colonic Neoplasms; Epidermal Growth Factor; ErbB Receptors; Farnesyltranstransferase; Humans; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organotechnetium Compounds; Quinolones; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome

2005